Gts Securities LLC Revance Therapeutics, Inc. Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$2.57 - $2.57 $4,626 - $4,626	1,800 Added 6.82%	28,200 $72,000
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $5,382 - $10,879	-2,300 Reduced 8.01%	26,400 $67,000
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $63,705 - $127,547	13,700 Added 91.33%	28,700 $141,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $5,810 - $11,200	1,000 Added 7.14%	15,000 $131,000
Q3 2023 Nov 15, 2023	BUY	$11.47 - $25.07 $160,580 - $350,980	14,000 New	14,000 $160,000

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.